Page last updated: 2024-11-04

salicylsalicylic acid and Diabetes Mellitus, Type 1

salicylsalicylic acid has been researched along with Diabetes Mellitus, Type 1 in 1 studies

salicylsalicylic acid: structure
salsalate : A dimeric benzoate ester obtained by intermolecular condensation between the carboxy of one molecule of salicylic acid with the phenol group of a second. It is a prodrug for salycylic acid that is used for treatment of rheumatoid arthritis and osteoarthritis and also shows activity against type II diabetes.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
" In order to improve NO bioavailability within the vessel wall in type-1 diabetes, we investigated treatment strategies that improve eNOS phosphorylation and NO-dependent vasorelaxation."1.42Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice. ( de Crom, R; Habib, SL; Janardhanan, P; Krishnan, M; Mohan, S; Natarajan, M; Reddick, RL; Roman, L; van Haperen, R, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krishnan, M1
Janardhanan, P1
Roman, L1
Reddick, RL1
Natarajan, M1
van Haperen, R1
Habib, SL1
de Crom, R1
Mohan, S1

Other Studies

1 other study available for salicylsalicylic acid and Diabetes Mellitus, Type 1

ArticleYear
Enhancing eNOS activity with simultaneous inhibition of IKKβ restores vascular function in Ins2(Akita+/-) type-1 diabetic mice.
    Laboratory investigation; a journal of technical methods and pathology, 2015, Volume: 95, Issue:10

    Topics: Animals; Aorta; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus, Type 1; Dietary Supplements; E

2015